4,384 trials (keyword fallback)
Diabetes Mellitus · Hypertension · Metabolic Disease
Primary: Change in BMI Standard Deviation Score — -0.12; -0.06 Standard Deviation Score — p=0.007
Obesity
Primary: Change in Body Mass Index Z-score — -0.01; 0.00; -0.04 Z-Score
Chronic Kidney Disease · Cardiovascular Disease · Metabolic Syndrome
Primary: Change is Leptin to Adiponectin Ratio (LAR) — 2.2; 1.3; 1.3; 1.4 ng/micrograms
Chronic Myelomonocytic Leukemia-2 · Myelodysplastic Syndrome · Myeloproliferative Neoplasm
Primary: Overall Survival of Patients Over Age 60 With Newly Diagnosed AML/High Risk MDS — 7 participants
Pediatric Obesity
Primary: Feasibility (Parents' Interest in the SBIRT.) — 84.3; NA; NA; NA percentage of parents
Obesity · Infertility
Primary: Luteinizing Hormone Pulse Amplitude — 2.73; 1.12 IU/L
Obesity
Primary: Change in Adult Body Mass Index — 0.3; -0.1 kg/m2 — p=0.67
Brain Neoplasms
Primary: Establish a Safe Dose for Oral 5-ALA Administration — 0; 0; 0; 0 Dose Limiting Toxicity
Obesity
Primary: Body Weight — 99.8; 101.0 kilogram (kg) — p=0.001
Obesity
Primary: Body Weight Change — -12.99 kg — p=<0.0001
Obesity · Osteopenia
Primary: Bone Mineral Density — -0.015; -0.008 grams/cm^2
Overweight · Obesity
Primary: Change in BMI z Score — -0.06; -0.09 BMI z score units — p=0.3928
Breast Feeding, Exclusive
Primary: Exclusive Breastfeeding (EBF) — 9; 4; 11; 13 Participants
Obesity, Childhood · Eating Behavior
Primary: Child Body Mass Index — 17.83; 18.78 kg/m-squred
Severe Obesity
Primary: Body Mass Index — 10.1; 4.6 percentage (body mass index)